Mustafa Dikilitaş

894 total citations
39 papers, 600 citations indexed

About

Mustafa Dikilitaş is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Mustafa Dikilitaş has authored 39 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Mustafa Dikilitaş's work include Gastric Cancer Management and Outcomes (8 papers), Colorectal Cancer Treatments and Studies (7 papers) and Cancer Treatment and Pharmacology (5 papers). Mustafa Dikilitaş is often cited by papers focused on Gastric Cancer Management and Outcomes (8 papers), Colorectal Cancer Treatments and Studies (7 papers) and Cancer Treatment and Pharmacology (5 papers). Mustafa Dikilitaş collaborates with scholars based in Türkiye, United States and Taiwan. Mustafa Dikilitaş's co-authors include Metin Özkan, Halıt Karaca, Velı Berk, Mikail Yarlıoğlueş, Mehmet Güngör Kaya, Mahmut Akpek, Yat Yin Lam, Esma Kaya, Nihat Kalay and İdris Ardıç and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Mustafa Dikilitaş

38 papers receiving 585 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mustafa Dikilitaş Türkiye 12 327 221 210 107 56 39 600
Brian Bird Ireland 11 279 0.9× 150 0.7× 106 0.5× 65 0.6× 65 1.2× 37 536
Elly Barry United States 12 310 0.9× 519 2.3× 174 0.8× 157 1.5× 98 1.8× 24 1.2k
Mary T. Vooletich United States 6 421 1.3× 522 2.4× 103 0.5× 55 0.5× 36 0.6× 12 689
Paraskevi Roussou Greece 13 138 0.4× 164 0.7× 75 0.4× 100 0.9× 120 2.1× 21 528
Daniela Di Lisi Italy 15 178 0.5× 436 2.0× 114 0.5× 121 1.1× 31 0.6× 59 607
Carol Zhao United States 14 139 0.4× 242 1.1× 459 2.2× 86 0.8× 36 0.6× 30 623
Sarah Hartmann Hungary 8 424 1.3× 363 1.6× 132 0.6× 96 0.9× 59 1.1× 9 696
John Syrios Greece 12 297 0.9× 183 0.8× 141 0.7× 77 0.7× 77 1.4× 22 574
Mustafa Altınbaş Türkiye 12 202 0.6× 158 0.7× 120 0.6× 145 1.4× 41 0.7× 47 670
J. Shapira Israel 14 232 0.7× 125 0.6× 149 0.7× 136 1.3× 78 1.4× 41 672

Countries citing papers authored by Mustafa Dikilitaş

Since Specialization
Citations

This map shows the geographic impact of Mustafa Dikilitaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mustafa Dikilitaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mustafa Dikilitaş more than expected).

Fields of papers citing papers by Mustafa Dikilitaş

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mustafa Dikilitaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mustafa Dikilitaş. The network helps show where Mustafa Dikilitaş may publish in the future.

Co-authorship network of co-authors of Mustafa Dikilitaş

This figure shows the co-authorship network connecting the top 25 collaborators of Mustafa Dikilitaş. A scholar is included among the top collaborators of Mustafa Dikilitaş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mustafa Dikilitaş. Mustafa Dikilitaş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dikilitaş, Mustafa, et al.. (2023). Clinicopathological Features of Young Gastric Cancer and New Inflammatory Prognostic Markers. Acta Oncologica Turcica. 56(2). 90–96. 1 indexed citations
3.
Dikilitaş, Mustafa, et al.. (2021). Acute sunitinib neurotoxicity. Cancer Treatment and Research Communications. 27. 100366–100366. 3 indexed citations
4.
Dikilitaş, Mustafa. (2020). Why Adjuvant and Neoadjuvant Therapy Failed in HCC. Can the New Immunotherapy Be Expected to Be Better?. Journal of Gastrointestinal Cancer. 51(4). 1193–1196. 8 indexed citations
5.
Karaca, Halıt, Oktay Bozkurt, Ersin Özaslan, et al.. (2014). Positive Effects of Oral β-Glucan on Mucositis and Leukopenia in Colorectal Cancer Patients Receiving Adjuvant FOLFOX-4 Combination Chemotherapy. Asian Pacific Journal of Cancer Prevention. 15(8). 3641–3644. 17 indexed citations
6.
Bılıcı, Ahmet, et al.. (2014). Modified Docetaxel and Cisplatin in Combination with Capecitabine (DCX) as a First-Line Treatment in HER2-Negative Advanced Gastric Cancer. Asian Pacific Journal of Cancer Prevention. 15(20). 8661–8666. 7 indexed citations
7.
Altınbaş, Mustafa, et al.. (2014). The effect of small-molecular-weight heparin added to chemotherapy on survival in small-cell lung cancer - A retrospective analysis. Indian Journal of Cancer. 51(3). 324–324. 7 indexed citations
8.
Özkan, Metin, Serdar Şıvgın, İsmail Koçyiğit, et al.. (2012). Do thrombophilic gene mutations have a role on thromboembolic events in cancer patients?. Asia-Pacific Journal of Clinical Oncology. 8(3). e34–41. 11 indexed citations
9.
Eroğlu, Celalettin, et al.. (2012). The effect of being overweight on survival in patients with gastric cancer undergoing adjuvant chemoradiotherapy. European Journal of Cancer Care. 22(1). 133–140. 9 indexed citations
10.
Kaya, Mehmet Güngör, Metin Özkan, Özgür Günebakmaz, et al.. (2012). Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study. International Journal of Cardiology. 167(5). 2306–2310. 222 indexed citations
11.
Yıldız, Ramazan, Mustafa Beneklı, Metin Özkan, et al.. (2012). Bevacizumab every 4 weeks is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancer. Journal of Cancer Research and Clinical Oncology. 138(11). 1845–1852. 4 indexed citations
12.
Dikilitaş, Mustafa, et al.. (2010). Hypoglycemia in a Patient With Metastatic Gastrointestinal Stromal Tumor: Is Chemotherapy a Reasonable Option for Symptom Control?. 1 indexed citations
13.
Karaca, Halıt, et al.. (2009). Recovery of paraneoplastic hypercalcemia by sunitinib treatment for renal cell carcinoma: a case report and review of the literature. Medical Oncology. 27(3). 1023–1026. 10 indexed citations
14.
Özkan, Metin, et al.. (2009). Triple-negative breast cancer: immunohistochemical correlation with basaloid markers and prognostic value of survivin. Medical Oncology. 27(1). 34–39. 32 indexed citations
15.
Er, Özlem, Mevlüde İnanç, Mustafa Dikilitaş, et al.. (2009). VEGF, EGF, HGF, and PDGF levels during chemotherapy in patients with metastatic colorectal cancer. Journal of Clinical Oncology. 27(15_suppl). 4057–4057. 2 indexed citations
16.
Kalender, Mehmet, Şeniz Demiryürek, Serdar Öztuzcu, et al.. (2009). Association Between the Thr431Asn Polymorphism of the ROCK2 Gene and Risk of Developing Metastases of Breast Cancer. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 18(11). 583–591. 28 indexed citations
17.
Erkurt, Mehmet Ali, İsmet Aydoğdu, Mustafa Dikilitaş, et al.. (2008). Effects of Cyanocobalamin on Immunity in Patients with Pernicious Anemia. Medical Principles and Practice. 17(2). 131–135. 38 indexed citations
18.
Kuku, İrfan, Emın Kaya, Mehmet Ali Erkurt, et al.. (2004). Malatya ve çevresi ABO ve Rh kan grubu dağılımı. DergiPark (Istanbul University). 11(4). 213–215. 1 indexed citations
19.
Kuku, İrfan, et al.. (2004). Hiperlökositozlu lösemi hastalarımızda terapötik ve proflaktik lökoferez deneyimlerimiz. DergiPark (Istanbul University). 11(4). 1 indexed citations
20.
Kaya, Emın, et al.. (2003). Blastic natural killer cell leukaemia with skin involvement: a case report. Journal of the European Academy of Dermatology and Venereology. 18(1). 86–88. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian Bird Breakdown of academic impact, for papers by Elly Barry Breakdown of academic impact, for papers by Mary T. Vooletich Breakdown of academic impact, for papers by Paraskevi Roussou Breakdown of academic impact, for papers by Daniela Di Lisi Breakdown of academic impact, for papers by Carol Zhao Breakdown of academic impact, for papers by Sarah Hartmann Breakdown of academic impact, for papers by John Syrios Breakdown of academic impact, for papers by Mustafa Altınbaş Breakdown of academic impact, for papers by J. Shapira
Rankless by CCL
2026